Has John McIntyre, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,443 in general payments to John McIntyre, MD across 64 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John McIntyre, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John McIntyre, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John McIntyre, MD

Otolaryngology · Fort Worth, TXNPI 1851591648

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,941 of the $3,443 with a category attached, or 85.4%. Inspire Medical Systems, Inc. accounts for 60.8% of it on its own, with 17 other manufacturers making up the rest.

$3,443in general payments, 2019–2025

Across 64 payments — averaging $53.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$2K
Stryker$335
Acclarent, Inc$304
Intersect ENT, Inc.$122
Regeneron Healthcare Solutions, Inc.$85
Medtronic$77
plus $427 from 12 others

$37,510in research payments, 2019–2025

Across 9 payments — averaging $4167.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Intersect ENT, Inc.$25K
Aerin Medical Inc.$7K
Medtronic$5K

What the payments were for

Travel & lodging$50215%
Food & beverage$2,94185%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	27	$2,092
Stryker	4	$335
Acclarent, Inc	4	$304
Intersect ENT, Inc.	2	$122
Regeneron Healthcare Solutions, Inc.	3	$85
Medtronic(2 entities)	4	$77
Smith+Nephew	3	$69
Aerin Medical Inc.	3	$64
Integra Lifesciences Corporation	2	$53
GSK	2	$40
Alcon	1	$36
Optinose US, Inc.	2	$34
Olympus America Inc.	2	$32
ARS Pharmaceuticals Operations, Inc.	1	$26
C2dx, Inc	1	$21
Novartis	1	$20
Merck	1	$18
Hologic Sales And Service, LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire$1,444
RELIEVA SPINPLUS Balloon Sinuplasty System$204
SCOPIS ENT$174
Inspire Upper Airway Stimulation System$152
TruDi Nav Cable$145
SPIROX - LATERA$139
SINUVA$100

How this compares

$3,443 in reported general payments places this provider in the 65th percentile of 729 otolaryngology providers in Texas.

See all otolaryngology providers in Texas →

Medicare billing

Part B allowed, 2024

$347,470

Medicare patients

476

Services billed

6,441

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
CefuroximeCefuroxime Axetil	106	$3,183
Epinephrine	18	$1,574
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	13	$1,487
Azelastine Hcl	32	$1,204
Ipratropium Bromide	32	$1,101
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	76	$721
Clarithromycin	18	$620
Mupirocin	78	$594
Montelukast Sodium	64	$587
Methylprednisolone	65	$474
Ofloxacin	14	$427
Cephalexin	45	$386
Prednisone	64	$291
Doxycycline Hyclate	12	$149
Omeprazole	16	$128

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Fort Worth

Marc DeanFort Worth$486K
Jeremy WatkinsFort Worth$17K
Jesse SmithFort Worth$16K
Amber LuongHouston$426K
Arjuna KuperanHouston$348K
Ronald KuppersmithCollege Station$325K
Ron KarniHouston$317K
Philip ChenSan Antonio$305K
Jordan RihaniSouthlake$280K
Keith MathenyFrisco$269K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →